Argues for a new paradigm for the assessment of efficacy endpoints, given described limitations of the current Response Evaluation Criteria In Solid Tumors (RECIST) system. 2012
https://cancerres.aacrjournals.org/content/72/20/5145.full
United States · California · Health → Wellness
Thumb up · 0